Literature DB >> 32532944

Prognosis of COVID-19: Changes in laboratory parameters.

Maria Lagadinou1, Elena E Salomou2, Nicholas Zareifopoulos1, Markos Marangos2, Charalambos Gogos2, Dimitrios Velissaris3.   

Abstract

INTRODUCTION: Since December 2019, an outbreak of coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome - Coronavirus 2 (SARS-CoV-2) emerged in China and has become a global threat. Comparison of hematological parameters between mild and severe cases of SARS-CoV 2 is so far limited, but significant differences in parameters such as interleukin-6, d-dimers, glucose, fibrinogen and C-reactive protein have been already reported.
PURPOSE: In this study we analyzed the changes observed in easily measured blood biomarkers in the patients and provided evidence of how these markers can be used as prognostic factors of the disease.
METHODS: Demographic characteristics, detailed medical history, and laboratory findings of all enrolled SARS-CoV 2 infection positive patients who were referred to Patras University Hospital from the period of March 4th 2020 (when first confirmed case in Greece appeared in our hospital) until April 4th 2020 were extracted from electronic medical records and analyzed.
RESULTS: We provided evidence that some very common laboratory values can be used as independent predictive factors in SARS-CoV 2 infection. Despite the retrospective nature of this study and the small number of subjects analyzed, we showed that NLR, LDH, d-dimers, CRP, fibrinogen and ferritin can be used early at the patient's first visit for SARS-CoV 2 infection symptoms and can predict the severity of infection.
CONCLUSION: More studies are warranted to further objectively confirm the clinical value of prognostic factors related to SARS-CoV 2 and establish an easy-to-get panel of laboratory findings for evaluating the disease severity.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32532944

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  11 in total

1.  Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis.

Authors:  Xiaoming Xiong; Jianhua Chi; Qinglei Gao
Journal:  Thromb J       Date:  2021-05-19

2.  Evaluation of the relationship between laboratory parameters and pulmonary function tests in COVID-19 patients.

Authors:  Buğra Kerget; Alperen Aksakal; Ferhan Kerget
Journal:  Int J Clin Pract       Date:  2021-04-27       Impact factor: 3.149

3.  Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality.

Authors:  Katia Lino; Gabriel Macedo Costa Guimarães; Lilian Santos Alves; Any Caroline Oliveira; Renan Faustino; Cintia Souza Fernandes; Gleiser Tupinambá; Thalia Medeiros; Andrea Alice da Silva; Jorge Reis Almeida
Journal:  Braz J Infect Dis       Date:  2021-03-15       Impact factor: 3.257

Review 4.  The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis.

Authors:  Roshan Kumar Mahat; Suchismita Panda; Vedika Rathore; Sharmistha Swain; Lalendra Yadav; Sumesh Prasad Sah
Journal:  Clin Epidemiol Glob Health       Date:  2021-03-20

5.  Diagnostic Delay of Pulmonary Embolism in COVID-19 Patients.

Authors:  Federica Melazzini; Margherita Reduzzi; Silvana Quaglini; Federica Fumoso; Marco Vincenzo Lenti; Antonio Di Sabatino
Journal:  Front Med (Lausanne)       Date:  2021-04-30

6.  The Role of Na+/K+-ATPase in the Development of Hyponatrenemia under Conditions of Hypoxic Stress in Patients with SARS-CoV-2 Infection.

Authors:  S H Jafarova; S A Adnaev; R T Guliyeva; N H Jafar
Journal:  Bull Exp Biol Med       Date:  2022-01-08       Impact factor: 0.804

7.  Evaluation of ferritin level in COVID-19 patients and its inflammatory response.

Authors:  Jing Chen; Zheng-Xin He; Fun-Kun Wang
Journal:  Appl Nanosci       Date:  2022-02-03       Impact factor: 3.674

8.  Biomarker identification using dynamic time warping analysis: a longitudinal cohort study of patients with COVID-19 in a UK tertiary hospital.

Authors:  Hannah Burke; Anna Freeman; Paul O'Regan; Oskar Wysocki; Andre Freitas; Ahilanandan Dushianthan; Michael Celinski; James Batchelor; Hang Phan; Florina Borca; Natasha Sheard; Sarah Williams; Alastair Watson; Paul Fitzpatrick; Dónal Landers; Tom Wilkinson
Journal:  BMJ Open       Date:  2022-02-15       Impact factor: 2.692

9.  National Early Warning Score 2 and laboratory predictors correlate with clinical deterioration in hospitalized patients with COVID-19.

Authors:  Gulsah Tuncer; Serkan Surme; Osman F Bayramlar; Hatice K Karanalbant; Betul Copur; Meltem Yazla; Esra Zerdali; Inci Y Nakir; Ayse Rk Cinar; Ahmet Buyukyazgan; Hatice Balli; Yesim Kurekci; Serap Simsek-Yavuz; Mehmet M Sonmez; Gonul Sengoz; Filiz Pehlivanoglu
Journal:  Biomark Med       Date:  2021-07-21       Impact factor: 2.851

10.  Integrative management of critical case of Covid 19 with Ayurveda and modern medicine: A case report.

Authors:  Amit Nakanekar; Siddharth Kulkarni; Punam Khobarkar; Minal Belsare
Journal:  J Ayurveda Integr Med       Date:  2021-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.